A snapshot of biologic drug development: Challenges and opportunities.

about

Establishment of a Predictive In Vitro Assay for Assessment of the Hepatotoxic Potential of Oligonucleotide Drugs Assessing single-stranded oligonucleotide drug-induced effects in vitro reveals key risk factors for thrombocytopenia.

P2860

Q28552808-E178F6EA-6361-4E5A-8823-DA876E2833BE Q47109845-F452F6B3-4B1B-4C56-AEBF-A2892C0B2DAC

P2860

A snapshot of biologic drug development: Challenges and opportunities.

Item

http://www.wikidata.org/entity/Q38651271

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

A snapshot of biologic drug development: Challenges and opportunities.

@en

type

Item

label

A snapshot of biologic drug development: Challenges and opportunities.

@en

prefLabel

A snapshot of biologic drug development: Challenges and opportunities.

@en

P1476

A snapshot of biologic drug development: Challenges and opportunities.

@en

P2093

E Blomme

http://www.w3.org/2001/XMLSchema#string

K Barnhart

http://www.w3.org/2001/XMLSchema#string

L Andrews

http://www.w3.org/2001/XMLSchema#string

S Ralston

http://www.w3.org/2001/XMLSchema#string

P2860

Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia

Preclinical development of monoclonal antibodies: considerations for the use of non-human primates

Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer

Current prospects for RNA interference-based therapies

Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1

Immunogenicity of protein therapeutics

CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia

Monoclonal antibody TGN1412 trial failure explained by species differences in CD28 expression on CD4+ effector memory T-cells

Antisense oligonucleotide therapies: the promise and the challenges from a toxicologic pathologist's perspective.

Gene therapy for blindness.

P304

1279-1285

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0960327115603594

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

284785446

http://www.w3.org/2001/XMLSchema#string

P698

26614816

http://www.w3.org/2001/XMLSchema#string

A snapshot of biologic drug development: Challenges and opportunities.

about

P2860

P2860

A snapshot of biologic drug development: Challenges and opportunities.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698